Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1053/j.semperi.2015.12.007 http://scihub22266oqcxt.onion/10.1053/j.semperi.2015.12.007 C4808371!4808371!26791055     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Semin+Perinatol 2016 ; 40 (3): 203-12 Nephropedia Template TP {{tp|p=26791055|t=2016. NEONATAL ABSTINENCE SYNDROME: PHARMACOLOGIC STRATEGIES FOR THE MOTHER AND INFANT |pdf=|usr=}}{{26791055}} gab.com Text NEONATAL ABSTINENCE SYNDROME: PHARMACOLOGIC STRATEGIES FOR THE MOTHER AND INFANT JO: Semin Perinatol http://www.kidney.de/pget.php?&tw=1&pmid=26791055 #FOAvip Opioid use in pregnancy has increased dramatically over the past decade. Since prenatal opioid use is associated with numerous obstetrical and neonatal complications, this now has become a major public health problem. In particular, in utero opioid exposure can result in neonatal abstinence syndrome (NAS) which is a serious condition characterized by central nervous system hyperirritability and autonomic nervous system dysfunction. The present review seeks to define current practices regarding the approach to the pregnant mother and neonate with prenatal opiate exposure. Although the cornerstone of prenatal management of opioid dependence is opioid maintenance therapy, the ideal agent has yet to be definitively established. Pharmacologic management of NAS is also highly variable and may include an opioid, barbiturate, and/or ?-agonist. Genetic factors appear to be associated with the incidence and severity of NAS. Establishing pharmacogenetic risk factors for the development of NAS has the potential for creating opportunities for ?personalized genomic medicine? and novel, individualized therapeutic interventions. Twit Text FOAVip NEONATAL ABSTINENCE SYNDROME: PHARMACOLOGIC STRATEGIES FOR THE MOTHER AND INFANT ????Semin Perinatol http://www.kidney.de/pget.php?&tw=1&pmid=26791055 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26791055 #FOAvip English Wikipedia <ref>{{Cite pmid|26791055}}</ref> NEONATAL ABSTINENCE SYNDROME: PHARMACOLOGIC STRATEGIES FOR THE MOTHER AND INFANT #MMPMID26791055 Kraft WK; Stover MW; Davis JM Semin Perinatol 2016[Apr]; 40 (3): 203-12 PMID26791055show ga Opioid use in pregnancy has increased dramatically over the past decade. Since prenatal opioid use is associated with numerous obstetrical and neonatal complications, this now has become a major public health problem. In particular, in utero opioid exposure can result in neonatal abstinence syndrome (NAS) which is a serious condition characterized by central nervous system hyperirritability and autonomic nervous system dysfunction. The present review seeks to define current practices regarding the approach to the pregnant mother and neonate with prenatal opiate exposure. Although the cornerstone of prenatal management of opioid dependence is opioid maintenance therapy, the ideal agent has yet to be definitively established. Pharmacologic management of NAS is also highly variable and may include an opioid, barbiturate, and/or ?-agonist. Genetic factors appear to be associated with the incidence and severity of NAS. Establishing pharmacogenetic risk factors for the development of NAS has the potential for creating opportunities for ?personalized genomic medicine? and novel, individualized therapeutic interventions. äNEONATAL ABSTINENCE SYNDROME: PHARMACOLOGIC STRATEGIES FOR THE MOTHER (epmc).pdf DeepDyve Pubget Overpricing